<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="483">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05154864</url>
  </required_header>
  <id_info>
    <org_study_id>1024869</org_study_id>
    <nct_id>NCT05154864</nct_id>
  </id_info>
  <brief_title>Ultrafiltration in Pediatric Cardiac Surgery: An Observational Cohort Study</brief_title>
  <official_title>The Optimal Ultrafiltration Protocol in Pediatric Cardiac Surgery: An Observational Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IWK Health Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IWK Health Centre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Infants and children undergoing cardiac surgery with cardiopulmonary bypass (CPB) can&#xD;
      experience systemic inflammation that prolongs post-operative recovery. Ultrafiltration is an&#xD;
      intra-opreative technique that is hypothesized to extract circulating inflammatory mediators&#xD;
      during the CPB time. There have been only a few small studies looking at a limited number of&#xD;
      inflammatory marker profiles in this context. Our institution uses an innovative form of&#xD;
      ultrafiltration &quot;subzero-balance simple-modified ultrafiltration&quot; (SBUF-SMUF) throughout the&#xD;
      entire CPB time. SBUF-SMUF has been our standard of care for the last 5 years. This&#xD;
      observational seeks to describe the clinical and immunologic outcomes of infants and children&#xD;
      undergoing cardiac surgery with CBP and SBUF-SMUF.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 1, 2020</start_date>
  <completion_date type="Actual">June 30, 2021</completion_date>
  <primary_completion_date type="Actual">June 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Inflammatory Mediator Analysis</measure>
    <time_frame>Plasma and ultrafiltrate effluent at pre-specified time points: Pre-Sternotomy (20min), Post-Sternotomy (30 min), every 30 minutes during cardiopulmonary bypass, 0 hours post-ultrafiltration, 12 hours post-ultrafiltration, 24 hours post-ultrafiltration</time_frame>
    <description>Change in Concentrations of C1q, C2, C3, C3b, C4, C4b, C5, complement factor B, complement factor H, complement factor IC5a, CCL2 ,CCL3, CCL4, CCL5 (RANTES), CXCL1, CXCL2, CXCL10, GM-CSF, IL-1α, IL-1β, IL-1Ra, IL-2, IL-6, CXCL8 (IL-8), IL-10, IL-12 (p70), IL-17/IL-17A, IL-33, TNF (TNF-α), TRAIL, IFN-γ, E-Selectin, L-Selectin, P-Selectin, ICAM-1, VCAM-1, ET1.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Vasoactive-Ventilation-Renal (VVR) Score</measure>
    <time_frame>Pre-specified time points: ICU admission, 12,24,48,72,96,120 hours post-ultrafiltration.</time_frame>
    <description>Scale 0-60</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vasoactive-Inotrope Score (VIS)</measure>
    <time_frame>Pre-specified time points: ICU admission, 12,24,48,72,96,120 hours post-ultrafiltration.</time_frame>
    <description>Scale 0-40</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ventilation Index (VI)</measure>
    <time_frame>Pre-specified time points: ICU admission, 12,24,48,72,96,120 hours post-ultrafiltration.</time_frame>
    <description>Scale 0-40</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxygenation Index (OI)</measure>
    <time_frame>Pre-specified time points: ICU admission, 12,24,48,72,96,120 hours post-ultrafiltration.</time_frame>
    <description>Scale 0-20</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ventilation Time</measure>
    <time_frame>Through study completion, an average of 1 week.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intensive Care Unit Length of Stay</measure>
    <time_frame>Through study completion, an average of 1 week.</time_frame>
    <description>Standardized Discharge Criteria</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute Kidney Injury</measure>
    <time_frame>Through study completion, an average of 1 week.</time_frame>
    <description>Kidney Disease Improving Global Outcomes criteria with Stages 1-3</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Arterial Blood Gas</measure>
    <time_frame>Pre-specified time points: Pre-Sternotomy (20min), Post-Sternotomy (30 min), every 30 minutes during cardiopulmonary bypass, 0,12,24,48,72,96,120 hours post-ultrafiltration.</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Transfusion</measure>
    <time_frame>Measured through 24-hours post-operative</time_frame>
    <description>Red Blood Cell, Plasma and Platelet.</description>
  </other_outcome>
  <other_outcome>
    <measure>Complete Blood Counts</measure>
    <time_frame>Pre-specified time points: baseline, ICU admission, 12,24,48,72,96,120 hours post-ultrafiltration.</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Total Chest Tube Output</measure>
    <time_frame>Through study completion, an average of 1 week.</time_frame>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">40</enrollment>
  <condition>Congenital Heart Disease</condition>
  <condition>Inflammation</condition>
  <arm_group>
    <arm_group_label>SBUF-SMUF</arm_group_label>
    <description>All patients underwent standard of care cardiac surgery, cardiopulmonary bypass and SBUF-SMUF with effluent removal of 30 ml/kg/hr and physiologic solution replacement of 25ml/kg/hr.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>SBUF-SMUF</intervention_name>
    <description>Intra-operative continuous ultrafiltration</description>
    <arm_group_label>SBUF-SMUF</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Patient plasma samples and ultrafiltrate effluent samples.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Infants and children less than 30kg undergoing cardiac surgery with cardiopulmonary bypass&#xD;
        and subzero-balance simple modified ultrafiltration (SBUF-SMUF).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Congenital cardiac patients (&lt; 30kg) that have been consented to a planned cardiac&#xD;
             surgery procedure requiring cardiopulmonary bypass at the IWK Health Centre.&#xD;
&#xD;
          -  Patient or family consent to participate in the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient or family refusal to participate.&#xD;
&#xD;
          -  Known genetic syndrome with multi-organ abnormalities and immune dysfunction such as&#xD;
             DiGeorge Syndrome, Trisomy 18 or 13, Noonan syndrome.&#xD;
&#xD;
          -  Known immunodeficiency syndrome or bone marrow pathology.&#xD;
&#xD;
          -  Severe liver disease with abnormal synthetic liver function tests.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>15 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>IWK Health Centre</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <zip>B3K 6R8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>Bierer J, Henderson M, Stanzel R, Sett S, Horne D. Subzero balance - simple modified ultrafiltration (SBUF-SMUF) technique for pediatric cardiopulmonary bypass. Perfusion. 2021 Jun 18:2676591211027788. doi: 10.1177/02676591211027788. [Epub ahead of print]</citation>
    <PMID>34142611</PMID>
  </reference>
  <reference>
    <citation>Bierer J, Stanzel R, Henderson M, Sett S, Horne D. Ultrafiltration in Pediatric Cardiac Surgery Review. World J Pediatr Congenit Heart Surg. 2019 Nov;10(6):778-788. doi: 10.1177/2150135119870176. Review.</citation>
    <PMID>31701831</PMID>
  </reference>
  <verification_date>December 2021</verification_date>
  <study_first_submitted>November 8, 2021</study_first_submitted>
  <study_first_submitted_qc>December 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 13, 2021</study_first_posted>
  <last_update_submitted>December 9, 2021</last_update_submitted>
  <last_update_submitted_qc>December 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>IWK Health Centre</investigator_affiliation>
    <investigator_full_name>Dr. David Horne</investigator_full_name>
    <investigator_title>Congenital Cardiac Surgeon</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Heart Defects, Congenital</mesh_term>
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

